Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Showing entries 1 - 5 out of 308
Huang, J, Osthushenrich, T, MacNamara, A, Mälarstig, A, Brocchetti, S, Bradberry, S, Scarabottolo, L, Ferrada, E, Sosnin, S, Digles, D, Superti-Furga, G & Ecker, GF 2024, 'ProteoMutaMetrics: machine learning approaches for solute carrier family 6 mutation pathogenicity prediction', Rsc advances, vol. 14, no. 19, 00748, pp. 13083-13094. https://doi.org/10.1039/d4ra00748d

Activities

Exploiting Linked Open Data - the Power of Workflows

Gerhard Ecker
SLAS Conference on Compound Management in Industry and Academia
Conference, Talk or oral contribution
12.4.2016 - 12.4.2016

Quantitative structure-kinetics relationships - can we predict on and off-kinetics?

Gerhard Ecker
PSDI 2014 - Protein Structure Determination in Industry
Conference, Talk or oral contribution
4.11.2014 - 4.11.2014

the Open PHACTS Discovery Platform - Semantic data integration in Pharmacoinformatics

Gerhard Ecker
Summer School in Biotechnology
Conference, Talk or oral contribution
26.9.2014 - 26.9.2014

It's all about integration - from docking to structure-based classification and prediction of side effects

Gerhard Ecker
7th SFB Annual Symposium
Conference, Talk or oral contribution
10.9.2014 - 10.9.2014

The Open PHACTS Discovery Platform - Semantic data integration for medicinal chemists

Gerhard Ecker
23rd International Symposium on Medicinal Chemistry (EFMC-ISMC 2014)
Conference, Talk or oral contribution
8.9.2014 - 8.9.2014